Literature DB >> 1255460

Electron beam ionization mass fragmentographic analysis of tricyclic antidepressants in human plasma.

J T Biggs, W H Holland, S Chang, P P Hipps, W R Sherman.   

Abstract

A method for the measurement, in human plasma, of all tertiary and secondary tricyclic antidepressants prescribed in the United States is described. The method uses electron beam ionization GLC-mass spectrometry, employing a computer-controlled multiple-ion detector. This method, mass fragmentography, is used with internal standards for each drug. Plasma levels to as low as 10 ng/ml of the following drugs can be measured: amitriptyline, nortriptyline, doxepin, desmethyldoxepin, imipramine, desipramine, and protriptyline. Deuterium-labeled amitriptyline and imipramine are used as internal standards for those two drugs; for the other drugs, deuterated amitriptyline, nortriptyline, desmethyldoxepin, or desipramine is used. The method can measure up to 15 samples/hr, making it practical for large-scale studies of these drugs in patients. Spectra of each drug and examples of their analysis are given.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1255460     DOI: 10.1002/jps.2600650221

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

Review 1.  Plasma level monitoring of tricyclic antidepressant therapy.

Authors:  L F Gram
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

2.  Plasma tricyclic drug levels in amitriptyline-treated depressed patients.

Authors:  D S Robinson; T B Cooper; C L Ravaris; J O Ives; A Nies; D Bartlett; K R Lamborn
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

3.  Heroin addiction and pregnancy.

Authors:  R A Bashore; J S Ketchum; K J Staisch; C T Barrett; E G Zimmermann
Journal:  West J Med       Date:  1981-06

4.  Long-term antidepressant treatment: alterations in cerebral capillary permeability.

Authors:  S H Preskorn; B K Hartman; H B Clark
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.